(FM) Medicina Interna
Departamento académico
![Foto de (FM) Medicina Interna](/img/uploaded/8452893AAA5F941F264F1A56BAA0C395.jpg)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (26)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins
Microchemical Journal, Vol. 199
2023
-
Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Gut, Vol. 71, Núm. 9, pp. 1856-1866
-
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299
2021
-
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2
-
Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex
Chest, Vol. 160, Núm. 2, pp. 481-490
2020
-
A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future
International Journal of COPD, Vol. 15, pp. 2091-2100
-
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
Liver International, Vol. 40, Núm. 6, pp. 1467-1476
-
Screening in Lung Cancer: The Latest Evidence
Archivos de Bronconeumologia, Vol. 56, Núm. 1, pp. 7-8
2019
-
Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in Emergency Departments
European Journal of Internal Medicine, Vol. 65, pp. 69-77
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672
2017
-
Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers
Medicina Clinica, Vol. 149, Núm. 2, pp. 61-71
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence
Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009
2016
-
Defining the asthma-COPD overlap syndrome in a COPD Cohort
Chest, Vol. 149, Núm. 1, pp. 45-52
-
Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort
PLoS ONE, Vol. 11, Núm. 9
2015
-
Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD
Chest, Vol. 148, Núm. 1, pp. 159-168
-
What pulmonologists think about the asthma–COPD overlap syndrome
International Journal of COPD, Vol. 10, pp. 1321-1330